Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CRO BioDuro to Merge with Formex, a US CMO

publication date: Nov 12, 2015
BioDuro, a China-US CRO, has merged its US operations with Formex, an API formulation, development and cGMP manufacturing company located in San Diego. Both companies are owned by Bridgewest Group of San Diego. In July, Bridgewest bought BioDuro from PPD, a global CRO. Masood Tayebi, PhD, who is a Partner and CEO of Bridgewest, founded BioDuro in 2005, sold it to PPD in 2012, re-acquired the company, and now he has merged Formex, another Bridgewest biopharma investment, into BioDuro. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here